Delivery Order SPE2DB24D2100-SPE2DB25FBDFF

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,391.99 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LUMIGAN 0.01% eye drops, a specialty ophthalmic medication, in support of federal healthcare programs. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.16, is for the supply of LUMIGAN 0.01% eye drops in 5 ML containers. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,361.88 firm fixed-price contract is for the delivery of LUMIGAN 0.01% eye drops, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.22, is for the delivery of LUMIGAN 0.01% eye drops in 5ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite...
This federal contract award, valued at $3,631.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a specialty pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 17, 2024. It is not designated with a set-aside requirement,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,834.08 firm fixed price contract is for the delivery of Lumigan 0.01% eye drops, a prescription medication used to treat glaucoma. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award, with ID SPE2DB24D2011|SPE2DB25FBQMF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lumigan 0.01% eye drops, a medication used to treat glaucoma. The contract is a delivery order with a firm fixed price of $1,201.02 and a completion date of April 11, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LUMIGAN 0.01% eye drops in 5 ml containers. The contract is a firm fixed-price delivery order, with a ceiling value of $2,640.89 and a period of performance through May 13, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 to provide a...
This federal contract award, with a ceiling value of $1,917.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of LUMIGAN 0.01% Eye Drops, 5ML, with an ultimate completion date of July 10, 2024. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with any set-aside requirements. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lumigan 0.01% eye drops, a specialty ophthalmic medication, with a ceiling value of $14,705.32 and a completion date of June 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDFF
    Delivery Order

This is a $4,132.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LUMIGAN 0.01% eye drops 2.5ML, a medication used to treat glaucoma. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/2/25, 10:42 PM